MedTrace Logo

Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer

NCT00804258 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2015-11-06

No results posted yet for this study

Summary

RATIONALE: Palliative care may help improve the quality of life of patients with ovarian cancer who are undergoing intraperitoneal chemotherapy.

PURPOSE: This clinical trial is studying palliative care in patients with ovarian cancer who are undergoing intraperitoneal chemotherapy.

Conditions

Interventions

DRUG

intraperitoneal chemotherapy

OTHER

educational intervention

OTHER

medical chart review

OTHER

questionnaire administration

PROCEDURE

assessment of therapy complications

PROCEDURE

end-of-life treatment/management

PROCEDURE

psychosocial assessment and care

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Marcia Grant, RN, DNSc, FAAN · City of Hope Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00804258 on ClinicalTrials.gov